Taylor Morrison Home Statistics
Total Valuation
TMHC has a market cap or net worth of $6.34 billion. The enterprise value is $7.85 billion.
| Market Cap | 6.34B |
| Enterprise Value | 7.85B |
Important Dates
The last earnings date was Wednesday, February 11, 2026, before market open.
| Earnings Date | Feb 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TMHC has 96.33 million shares outstanding. The number of shares has decreased by -5.75% in one year.
| Current Share Class | 96.33M |
| Shares Outstanding | 96.33M |
| Shares Change (YoY) | -5.75% |
| Shares Change (QoQ) | -1.39% |
| Owned by Insiders (%) | 0.63% |
| Owned by Institutions (%) | 101.01% |
| Float | 95.68M |
Valuation Ratios
The trailing PE ratio is 8.47 and the forward PE ratio is 12.89. TMHC's PEG ratio is 8.96.
| PE Ratio | 8.47 |
| Forward PE | 12.89 |
| PS Ratio | 0.78 |
| Forward PS | 0.90 |
| PB Ratio | 1.01 |
| P/TBV Ratio | 1.13 |
| P/FCF Ratio | 8.16 |
| P/OCF Ratio | 7.76 |
| PEG Ratio | 8.96 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.52, with an EV/FCF ratio of 10.11.
| EV / Earnings | 10.03 |
| EV / Sales | 0.97 |
| EV / EBITDA | 6.52 |
| EV / EBIT | 6.75 |
| EV / FCF | 10.11 |
Financial Position
The company has a current ratio of 6.76, with a Debt / Equity ratio of 0.37.
| Current Ratio | 6.76 |
| Quick Ratio | 0.91 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | 1.94 |
| Debt / FCF | 3.04 |
| Interest Coverage | 24.77 |
Financial Efficiency
Return on equity (ROE) is 12.98% and return on invested capital (ROIC) is 11.11%.
| Return on Equity (ROE) | 12.98% |
| Return on Assets (ROA) | 7.60% |
| Return on Invested Capital (ROIC) | 11.11% |
| Return on Capital Employed (ROCE) | 13.47% |
| Weighted Average Cost of Capital (WACC) | 9.89% |
| Revenue Per Employee | $2.71M |
| Profits Per Employee | $260,833 |
| Employee Count | 3,000 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 0.99 |
Taxes
In the past 12 months, TMHC has paid $250.78 million in taxes.
| Income Tax | 250.78M |
| Effective Tax Rate | 24.07% |
Stock Price Statistics
The stock price has increased by +2.97% in the last 52 weeks. The beta is 1.59, so TMHC's price volatility has been higher than the market average.
| Beta (5Y) | 1.59 |
| 52-Week Price Change | +2.97% |
| 50-Day Moving Average | 62.98 |
| 200-Day Moving Average | 62.74 |
| Relative Strength Index (RSI) | 53.07 |
| Average Volume (20 Days) | 1,184,992 |
Short Selling Information
The latest short interest is 4.84 million, so 5.02% of the outstanding shares have been sold short.
| Short Interest | 4.84M |
| Short Previous Month | 5.17M |
| Short % of Shares Out | 5.02% |
| Short % of Float | 5.05% |
| Short Ratio (days to cover) | 5.57 |
Income Statement
In the last 12 months, TMHC had revenue of $8.12 billion and earned $782.50 million in profits. Earnings per share was $7.77.
| Revenue | 8.12B |
| Gross Profit | 1.90B |
| Operating Income | 1.16B |
| Pretax Income | 1.04B |
| Net Income | 782.50M |
| EBITDA | 1.20B |
| EBIT | 1.16B |
| Earnings Per Share (EPS) | $7.77 |
Balance Sheet
The company has $850.04 million in cash and $2.36 billion in debt, with a net cash position of -$1.51 billion or -$15.70 per share.
| Cash & Cash Equivalents | 850.04M |
| Total Debt | 2.36B |
| Net Cash | -1.51B |
| Net Cash Per Share | -$15.70 |
| Equity (Book Value) | 6.31B |
| Book Value Per Share | 65.19 |
| Working Capital | 6.89B |
Cash Flow
In the last 12 months, operating cash flow was $817.35 million and capital expenditures -$40.37 million, giving a free cash flow of $776.97 million.
| Operating Cash Flow | 817.35M |
| Capital Expenditures | -40.37M |
| Free Cash Flow | 776.97M |
| FCF Per Share | $8.07 |
Margins
Gross margin is 23.38%, with operating and profit margins of 14.33% and 9.63%.
| Gross Margin | 23.38% |
| Operating Margin | 14.33% |
| Pretax Margin | 12.83% |
| Profit Margin | 9.63% |
| EBITDA Margin | 14.83% |
| EBIT Margin | 14.33% |
| FCF Margin | 9.57% |
Dividends & Yields
TMHC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.75% |
| Shareholder Yield | 5.75% |
| Earnings Yield | 12.34% |
| FCF Yield | 12.26% |
Analyst Forecast
The average price target for TMHC is $78.38, which is 19.10% higher than the current price. The consensus rating is "Buy".
| Price Target | $78.38 |
| Price Target Difference | 19.10% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMHC has an Altman Z-Score of 3.85 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.85 |
| Piotroski F-Score | 4 |